GSK-205421

Study Sponsor: GSK

Study Title

A Phase 2, Non-Randomized, Controlled, Open-Label, Parallel-Group, Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-pregnant Subjects.

Medicine or Vaccine (generic name)

GSK3536855A

Sponsor Identification Number

205421

Trial Registry Identification Number(#'s)

NCT02690181 2015-003094-15

Medical Condition

Streptococcus agalactiae

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=205421

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02690181

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2015-003094-15

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is an extension study to 205468 (NCT01150123).

Date Added to this Site

September 2019